For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the arrival of Vyndamax and Attruby represents a significant change. These novel therapies protect the https://vyndamax724117.ampedpages.com/a-significant-attr-cm-advance-vyndamax-and-attruby-give-encouragement-69175716